A detailed history of Thomasville National Bank transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Thomasville National Bank holds 37,500 shares of SCPH stock, worth $126,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
37,500
Previous 37,500 -0.0%
Holding current value
$126,750
Previous $163,000 4.29%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$3.51 - $5.21 $2,457 - $3,647
700 Added 1.9%
37,500 $163,000
Q1 2024

Apr 10, 2024

BUY
$4.86 - $6.39 $18,468 - $24,282
3,800 Added 11.52%
36,800 $184,000
Q4 2022

Jan 10, 2023

BUY
$4.02 - $7.53 $22,109 - $41,415
5,500 Added 20.0%
33,000 $237,000
Q3 2022

Oct 03, 2022

BUY
$4.48 - $6.52 $56,000 - $81,500
12,500 Added 83.33%
27,500 $179,000
Q4 2021

Jan 18, 2022

BUY
$3.88 - $6.9 $58,200 - $103,500
15,000 New
15,000 $75,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $92.6M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Thomasville National Bank Portfolio

Follow Thomasville National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Thomasville National Bank with notifications on news.